Switch to:
GuruFocus has detected 5 Warning Signs with Sanofi SA $SNY.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Sanofi SA (NYSE:SNY)
Capital Expenditure
$-2,197 Mil (TTM As of Dec. 2016)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Sanofi SA's cash flow for capital expenditures for the six months ended in Dec. 2016 was $-931 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2016 was $-2,197 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sanofi SA Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2016 was $-2,197 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Sanofi SA Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Cash Flow_CPEX -2,344-2,170-2,602-2,198-2,345-2,115-1,789-1,792-3,020-2,197

Sanofi SA Semi-Annual Data

Jun12Dec12Jun13Dec13Jun14Dec14Jun15Dec15Jun16Dec16
Cash Flow_CPEX -986-1,084-960-792-865-1,006-865-2,180-1,348-931
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK